Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Fluids and Barriers of the CNS
Published in: Fluids and Barriers of the CNS 1/2021

Open Access 01-12-2021 | SARS-CoV-2 | Letter to the Editor

Response to the letter, entitled “Role of hemagglutinin esterase protein in neurological manifestation of COVID-19”

Author: Rashid Deane

Published in: Fluids and Barriers of the CNS | Issue 1/2021

Login to get access

Excerpt

In the letter to the Editor, entitled “Role of hemagglutinin esterase protein in neurological manifestation of COVID-19”, the authors [1] appear to indicate that a role was attributed to hemagglutinin esterase (HE) in the coronavirus disease 2019 (COVID-19) neurological manifestation in a recent review article [2]. However, in this review HE is mentioned once but there is no discussion on its function. In addition, there is no speculation on HE’s role in COVID-19 and specifically on the neurological manifestations of this infection in the review [2]. …
Literature
1.
Zandi M, Karami H, Soltani S. Role of hemagglutinin esterase protein in neurological manifestation of COVID-19. Fluids Barriers CNS. 2021;18:39.CrossRef
2.
McQuaid C, Brady M, Deane R. SARS-CoV-2: is there neuroinvasion? Fluids Barriers CNS. 2021;18(1):1–21.CrossRef
3.
Infantino M, Damiani A, Gobbi FL, Grossi V, Lari B, Macchia D, et al. Serological assays for SARS-CoV-2 infectious disease: benefits, limitations and perspectives. Isr Med Assoc J. 2020;22:203–10.PubMed
4.
Lahlou Y, El AB, Bamhaoud T. Genomic and molecular analysis of SARS-CoV-2 and the possible strategies of Covid-19 treatment—a review. IOSR J Pharm Biol Sci. 2020;13:39–47.
5.
Kim CH. Sars-cov-2 evolutionary adaptation toward host entry and recognition of receptor o-acetyl sialylation in virus–host interaction. Int J Mol Sci. 2020;21:1–34.
6.
Bagheri HS, Karimipour M, Heidarzadeh M, Rajabi H, Sokullu E, Rahbarghazi R. Does the global outbreak of COVID-19 or other viral diseases threaten the stem cell reservoir inside the body? Stem Cell Rev Rep. 2021;17:214–30.CrossRef
Metadata
Title
Response to the letter, entitled “Role of hemagglutinin esterase protein in neurological manifestation of COVID-19”
Author
Rashid Deane
Publication date
01-12-2021
Publisher
BioMed Central
Published in
Fluids and Barriers of the CNS / Issue 1/2021
Electronic ISSN: 2045-8118
DOI
https://doi.org/10.1186/s12987-021-00275-y

Other articles of this Issue 1/2021

Fluids and Barriers of the CNS 1/2021 Go to the issue

Research

A novel model of acquired hydrocephalus for evaluation of neurosurgical treatments

Research

Protecting P-glycoprotein at the blood–brain barrier from degradation in an Alzheimer’s disease mouse model

Research

Characterization of the blood–brain barrier in genetically diverse laboratory mouse strains

Research

Upright versus supine MRI: effects of body position on craniocervical CSF flow

Research

Brain pharmacokinetics of two BBB penetrating bispecific antibodies of different size

Research

Transfer of rhodamine-123 into the brain and cerebrospinal fluid of fetal, neonatal and adult rats